Your browser doesn't support javascript.
loading
Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment.
Wada, Masataka; Noda, Yoshihiro; Iwata, Yusuke; Tsugawa, Sakiko; Yoshida, Kazunari; Tani, Hideaki; Hirano, Yoji; Koike, Shinsuke; Sasabayashi, Daiki; Katayama, Haruyuki; Plitman, Eric; Ohi, Kazutaka; Ueno, Fumihiko; Caravaggio, Fernando; Koizumi, Teruki; Gerretsen, Philip; Suzuki, Takefumi; Uchida, Hiroyuki; Müller, Daniel J; Mimura, Masaru; Remington, Gary; Grace, Anthony A; Graff-Guerrero, Ariel; Nakajima, Shinichiro.
Afiliación
  • Wada M; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Noda Y; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Iwata Y; Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine, Yamanashi, Japan.
  • Tsugawa S; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Yoshida K; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Tani H; Tanenbaum Centre for Pharmacogenetics, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Hirano Y; Azrieli Adult Neurodevelopmental Centre, Centre for Addiction and Mental Health, Toronto, ON, Canada.
  • Koike S; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Sasabayashi D; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Katayama H; Department of Neuropsychiatry, Kyushu University, Fukuoka, Japan.
  • Plitman E; Neural Dynamics Laboratory, Research Service, VA Boston Healthcare System, and Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
  • Ohi K; Center for Evolutionary Cognitive Sciences, Graduate School of Art and Sciences, The University of Tokyo, Tokyo, Japan.
  • Ueno F; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, Toyama, Japan.
  • Caravaggio F; Research Center for Idling Brain Science, University of Toyama, Toyama, Japan.
  • Koizumi T; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Gerretsen P; Faculty of Medicine, University of Toronto, Toronto, ON, Canada.
  • Suzuki T; Department of Psychiatry, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Uchida H; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Müller DJ; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Mimura M; Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
  • Remington G; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
  • Grace AA; Brain Health Imaging Centre, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
  • Graff-Guerrero A; Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
  • Nakajima S; Department of Psychiatry, National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba, Japan.
Mol Psychiatry ; 27(7): 2950-2967, 2022 07.
Article en En | MEDLINE | ID: mdl-35444257

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Estimulación Transcraneal de Corriente Directa Límite: Humans Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Antipsicóticos / Clozapina / Estimulación Transcraneal de Corriente Directa Límite: Humans Idioma: En Revista: Mol Psychiatry Asunto de la revista: BIOLOGIA MOLECULAR / PSIQUIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Reino Unido